NCT04301674View on ClinicalTrials.gov

Metabolomics in Occupational Asthma

UnknownOBSERVATIONAL

Enrollment

80

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

June 1, 2023

Conditions

Asthma, Occupational

Interventions

DEVICE

Breath Biopsy

ReCIVA breath sampler (Owlstone Medical, Cambridge, UK)

Trial Locations (1)

Unknown

RECRUITING

Oslo University Hospital, Oslo

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Owlstone Ltd

INDUSTRY

lead

Oslo University Hospital

OTHER

NCT04301674 - Metabolomics in Occupational Asthma | Biotech Hunter | Biotech Hunter